Literature DB >> 9463567

[Hormonal therapy prolongs survival after the irradiation of locally advanced breast carcinomas: a randomized Phase-III study of the European Organization for Research and Treatment of Cancer (EORTC)].

H F Rauschecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9463567     DOI： 10.1007/bf03038231

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

Review 1.  Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy.

Authors:  G Bonadonna; P Valagussa; C Brambilla; A Moliterni; M Zambetti; L Ferrari
Journal:  Semin Oncol       Date:  1991-12       Impact factor: 4.929

2.  Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial.

Authors:  H Bartelink; R D Rubens; E van der Schueren; R Sylvester
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

3.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.

Authors:  B Fisher; S Anderson; C K Redmond; N Wolmark; D L Wickerham; W M Cronin
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

4.  Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792).

Authors:  R D Rubens; H Bartelink; E Engelsman; J L Hayward; N Rotmensz; R Sylvester; E van der Schueren; J Papadiamantis; S D Vassilaros; J Wildiers
Journal:  Eur J Cancer Clin Oncol       Date:  1989-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.